Dino A Feigelstock

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. pmc Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I
    Dino A Feigelstock
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, 29 Lincoln Drive, Bethesda, MD 20892, USA
    Virol J 7:44. 2010
  2. pmc Selection of hepatitis C virus resistant to ribavirin
    Dino A Feigelstock
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, 29 Lincoln Drive, Bethesda, MD 20892, USA
    Virol J 8:402. 2011
  3. pmc Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs
    Kathleen B Mihalik
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America
    PLoS ONE 8:e74027. 2013
  4. pmc Growth of hepatitis A virus in a mouse liver cell line
    Dino A Feigelstock
    Laboratory of Hepatitis, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20852, USA
    J Virol 79:2950-5. 2005

Collaborators

  • Kathleen B Mihalik

Detail Information

Publications4

  1. pmc Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I
    Dino A Feigelstock
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, 29 Lincoln Drive, Bethesda, MD 20892, USA
    Virol J 7:44. 2010
    ..To test our hypothesis, we analyzed Huh7 cell clones that support the efficient replication of HCV and analyzed the RIG-I gene...
  2. pmc Selection of hepatitis C virus resistant to ribavirin
    Dino A Feigelstock
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, 29 Lincoln Drive, Bethesda, MD 20892, USA
    Virol J 8:402. 2011
    ..Therefore, understanding HCV resistance to ribavirin could be of major importance. In an approach to understand the effect of ribavirin on HCV replication and HCV resistance, we have selected a ribavirin resistant mutant of HCV in vitro...
  3. pmc Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs
    Kathleen B Mihalik
    Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America
    PLoS ONE 8:e74027. 2013
    ..Therefore, understanding the mechanism of HCV resistance to ribavirin and cross resistance to other antiviral drugs could be of major importance...
  4. pmc Growth of hepatitis A virus in a mouse liver cell line
    Dino A Feigelstock
    Laboratory of Hepatitis, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20852, USA
    J Virol 79:2950-5. 2005
    ..Our results demonstrate that mouse hepatocyte-like cells code for all factors required for the efficient growth of HAV in cell culture...